Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

DIAGNOS said the future CARA version is also moving toward FDA filing as the legacy product stays cleared in the United States.

Summary by Globe Newswire
BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company...

6 Articles

Globe NewswireGlobe Newswire
+5 Reposted by 5 other sources
Center

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Left
67% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hamilton Spectator broke the news in Hamilton, Canada on Wednesday, April 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Brossard icon

Brossard

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal